Prevalence of oral manifestations of HIV infection in Rio de Janeiro, Brazil from 1988 to 2004

AIDS Patient Care and STDs

Volumn 21, Issue 10, 2007, Pages 724-731

  Ferreira, Sonia ^a,b   Noce, Cesar ^c,g   Silva Jr , Arley ^d   Gonçalves, Lúcio ^d   Torres, Sandra ^c   Meeks, Valli ^e   Luiz, Ronir ^c   Dias, Eliane ^f  

^a UNIVERSITY OF MARYLAND   (United States)

^b Direito Público pela UFAL Especialista em Direito Penal e Processual Penal pela UCDB Direito Penal no Centro Universitário CESMAC Maceió AL   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d GAMA FILHO UNIVERSITY   (Brazil)

^e UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^f FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^g NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE DISTRIBUTION; APHTHOUS ULCER; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CHEILITIS; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EDUCATION; ERYTHEMATOUS CANDIDIASIS; FEMALE; GENDER; GINGIVA ERYTHEMA; HERPES SIMPLEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KAPOSI SARCOMA; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOUTH DISEASE; OPPORTUNISTIC INFECTION; ORAL WART; PERIODONTITIS; PSEUDOMEMBRANOUS CANDIDIASIS; RETROSPECTIVE STUDY; SALIVARY GLAND DISEASE; SMOKING; VERRUCA VULGARIS; VINCENT STOMATITIS; VIRUS LOAD;

ADOLESCENT; ADULT; AGING; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOUTH DISEASES; PREVALENCE; RETROSPECTIVE STUDIES; RNA, VIRAL; SEX CHARACTERISTICS; TIME FACTORS; VIRAL LOAD;

EID: 35448985782     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.0211     Document Type: Article

References (37)

1. UNAIDS. AIDS epidemic update: Special report on HIV/AIDS. Geneva: WHO, 2006.
2. a semanas epidemioló gicas de 2006. Brasília: Ministério da Saúde, 2006.
3. Levi GC, Vitória MAA. Fighting against AIDS: The Brazilian experience. AIDS 2002;16:2373-2383.
4. EC-Clearinghouse on oral problems related to HIV infection and WHO collaborating centre on oral manifestations of the immunodeficiency virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993;22:289-291.
5. Delta Coordinating Committee. Delta: A randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1996;348:283-291.
6. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996;335:1081-1090.
7. Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, Gonzalez-Ramirez I, Ponce-de-Leon S. The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1000 consecutive patients. A 12-year study in a referral center in Mexico. Medicine 2003;82:39-50.
8. Greenwood I, Zakrzewska JM, Robinson PG. Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years. Oral Dis 2002;8:90-94.
9. Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001;357:1411-1412.
10. Leigh JE, Shetty K, Fidel PL Jr. Oral opportunistic infections in HIV-positive individuals: Review and role of mucosal immunity. AIDS Patient Care STDs 2004;18:443-456.
11. Gaitán-Cepeda LA, Martínez-González M, Ceballos-Salobreña A. Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART. AIDS Patient Care STDs 2005;19:70-77.
12. Ortega KL. Aspectos demográficos, clínicos e odontológicos de 1200 pacientes HIV positivos do centro de atendimento a pacientes especialis (CAPE-FOUSP). São Paulo: São Paulo University, 2000.
13. Giovani EM. Estudo retrospectivo dos aspectos demográficos e das manifestações clínicas bucais e gerais, em pacientes com idade superior a 50 anos soropositivos para o HIV/Aids. São Paulo: São Paulo University, 2002.
14. Centers for Disease Control and Prevention. 1993 Revised Classification System for HIV Infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19.
15. Yeni PG, Hammer SM, Carpenter CCJ, et al. Antiretroviral treatment for adult HIV infection in 2002-Updated recommendations of the International AIDS Society - USA Panel. JAMA 2002;288:222-235.
16. Ministério da Saúde. Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV 2004. Brasília, 2004. http://www.aids.gov.br (Last accessed January 2007).
17. Stoff DM, Khalsa JH, Monjan A, Portegies P. Introduction: HIV/AIDS and aging. AIDS 2004;18(Suppl 1):S1-S2.
18. Peru - Epidemiological fact sheets on HIV/AIDS and sexually transmitted infections. UNAIDS, PAHO, UNICEF & WHO, 2004 update. www.who.int/Global Atlas (Last accessed July 2005).
19. Centers for Disease Control and Prevention. Trends in HIV/AIDS diagnoses - 33 states, 2001-2004. MMWR 2005;54:1149-1153.
20. Hijjar MA. Tuberculose: desafio permanente. Cad Saude Publica 2005;21:348.
21. Tackling poverty in tuberculosis control. Lancet 2005;366:2063.
22. Ranganathan K, Umadevi M, Saraswathi TR, Kumarasamy N, Solomon S, Johnson N. Oral lesions and conditions associated with human immunodeficiency virus infection in 1000 south Indian patients. Ann Acad Med Singapore 2004;33(Suppl 4):37S-42S.
23. Kerdpon D, Pongsiriwet S, Pangsomboon K, et al. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients. Oral Dis 2004;10:138-144.
24. Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA. Decline in the rate of opportunistic infections following the introduction of highly active antiretroviral therapy. J Oral Pathol Med 2000;29:336-341.
25. Taybos G. Oral changes associated with tobacco use. Am J Med Sci 2003;326:179-182.
26. Pinheiro A, Marcenes W, Zakrzewska JM, Robinson PG. Dental and oral lesions in HIV infected patients: A study in Brazil. Int Dent J 2004;54:131-137.
27. Fabro SML, Rath IBS, Grando LJ, Gil JN, Schlemper JB, Pellegrini GF. Estudo das manifestações estomatológicas em pacientes infectados pelo HIV, atendidos no Hospital Nereu Ramos-Florianópolis-SC, Brasil. RPG 2002;9:12-19.
28. Ferreira RI, Valença Neto AAP, Vianna DC, Sarmento VA, Falcão AFP, Raquim OM. Estudo da prevalência de alteraç ões bucais em pacientes HIV+ do Hospital Universitário Prof. Edgard Santos-Salvador, BA. Rev Fac Odonto UFBA 1999;18:22-27.
29. Volkweis MR, Rocha RS, Leonardo, LLN, Wagner JCB. Lesões bucais em pacientes aidéticos e tuberculosos, relacionadas com a contagem celular cd4+/cd8+. Pós-Grad Rev Fac Odontol Säo José dos Campos 2001;4:74-82.
30. De Bernardis F, Tacconelli E, Mondello F, et al. Antiretroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility. FEMS Immunol Med Microbiol 2004;41:27-34.
31. Hilton JF, MacPhail LA, Pascasio L, et al. Self-care intervention to reduce oral candidasis recurrences in HIV-seropositive persons: A pilot study. Community Dent Oral Epidemiol 2004;32:190-200.
32. Reichart PA. US1 HIV - Changing patterns in HAART era, patient's quality of life and occupational risks. Oral Dis 2006;12(Suppl 1):3.
33. Porter SR. US8 Xerostomia. Oral Dis 2006;12(Suppl 1):4.
34. Rachid M, Schechter M. Manual de HIV/AIDS, 7th ed. Rio de Janeiro: Revinter, 2003.
35. Hoffman C, Kamps BS. HIV Medicine 2003, 1st ed. Paris: Flying Publisher; 2003.
36. Kauffman DE, Lichterfeld M, Altfeld M, Addo MM, Johnston MN, Lee PK, et al. Limited durability of viral control following treated acute HIV infection. Plos Medicine. 2004;1:137-148.
37. Goodkin K, Shapshak P, Asthana D, et al. Older age and plasma viral load in HIV-1 infection. AIDS 2004;18(Suppl 1):S87-S98.